These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7106896)

  • 1. Impairment of hepatic drug metabolism in patients with Budd-Chiari syndrome.
    Narang AP; Datta DV; Mathur VS
    Indian J Med Res; 1982 Apr; 75():567-73. PubMed ID: 7106896
    [No Abstract]   [Full Text] [Related]  

  • 2. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic drug metabolism in patients with intrahepatic cholestasis (author's transl)].
    Deschamps JP; Miguet JP; Vuitton D; Joanne C; Allemand H; Carayon P; Bechtel P; Gisselbrecht H
    Gastroenterol Clin Biol; 1979 May; 3(5):439-45. PubMed ID: 535711
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic metabolism of antipyrine in patients with acute pancreatitis].
    Lukaszyk A
    Przegl Lek; 1987; 44(2):273-6. PubMed ID: 3615930
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver failure and drug metabolism.
    Andreasen PB; Ranek L
    Scand J Gastroenterol; 1975; 10(3):293-7. PubMed ID: 1138332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Budd-Chiari syndrome: clinical presentation and diagnostic findings in 45 patients treated by surgery.
    Lang H; Oldhafer KJ; Weimann A; Gebel M; Wagner S; Böker K; Prokop M; Reimer P; Ringe B; Pichlmayr R
    Bildgebung; 1994 Sep; 61(3):173-81. PubMed ID: 7987058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK; Nanivadekar SA; Billimoria FR
    Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of renal cell carcinoma associated with Budd-Chiari syndrome: report of four cases and review of the literature.
    Kume H; Kameyama S; Kasuya Y; Tajima A; Kawabe K
    Eur J Surg Oncol; 1999 Feb; 25(1):71-5. PubMed ID: 10188859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Budd-Chiari syndrome, with special reference to secondary Budd-Chiari syndrome].
    Takada A; Kanayama R; Hasumura Y; Okumura Y; Ikegami H
    Saishin Igaku; 1969 May; 24(5):1055-62. PubMed ID: 4309517
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A; Ludkowski M; Nash R; Kugelmas M
    Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Galactose and antipyrine load tests in assessing the detoxification activity of the liver].
    Maestri G; D'Amore V; Angeli E
    Minerva Dietol Gastroenterol; 1979; 25(4):399-406. PubMed ID: 554030
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered drug metabolism in hepatosplenic schistosomiasis.
    Brant PC; Prata A
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):254-9. PubMed ID: 549210
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation-induced liver injury showing low intensity on T2-weighted images noted in Budd-Chiari syndrome.
    Mori H; Yoshioka H; Mori K; Ahmadi T; Okumura T; Saida Y; Itai Y
    Radiat Med; 2002; 20(2):69-76. PubMed ID: 12041701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.